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Background: The ability to query many independent biological databases using a common ontology-based semantic
model would facilitate deeper integration and more effective utilization of these diverse and rapidly growing resources.
Despite ongoing work moving toward shared data formats and linked identifiers, significant problems persist in
semantic data integration in order to establish shared identity and shared meaning across heterogeneous biomedical
data sources.
Results: We present five processes for semantic data integration that, when applied collectively, solve seven key
problems. These processes include making explicit the differences between biomedical concepts and database
records, aggregating sets of identifiers denoting the same biomedical concepts across data sources, and using
declaratively represented forward-chaining rules to take information that is variably represented in source databases
and integrating it into a consistent biomedical representation. We demonstrate these processes and solutions by
presenting KaBOB (the Knowledge Base Of Biomedicine), a knowledge base of semantically integrated data from
18 prominent biomedical databases using common representations grounded in Open Biomedical Ontologies.
An instance of KaBOB with data about humans and seven major model organisms can be built using on the order
of 500 million RDF triples. All source code for building KaBOB is available under an open-source license.
Conclusions: KaBOB is an integrated knowledge base of biomedical data representationally based in prominent,
actively maintained Open Biomedical Ontologies, thus enabling queries of the underlying data in terms of biomedical
concepts (e.g., genes and gene products, interactions and processes) rather than features of source-specific data
schemas or file formats. KaBOB resolves many of the issues that routinely plague biomedical researchers intending
to work with data from multiple data sources and provides a platform for ongoing data integration and development
and for formal reasoning over a wealth of integrated biomedical data.
Keywords: Knowledge representation and reasoning, Semantic data integration, Biomedical, Databases, Open biomedical
ontologies, Semantic web, OWL, RDFBackground
The depth and breadth of curated knowledge in molecu-
lar biomedicine is staggering. The 2015 Nucleic Acids
Research peer-reviewed compilation of molecular biomed-
ical databases lists 1,621 databases [1], many of which
hold millions of detailed records about biomedically sig-
nificant entities. Much contemporary biomedical research
depends on broad and unbiased assays at genomic scale.
Interpretation of the results of such assays, which gener-
ally implicate hundreds or even thousands of relevant
gene products (or polymorphisms, etc.) in the context of* Correspondence: Kevin.Livingston@ucdenver.edu
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unless otherwise stated.what is already known is particularly challenging, and
existing approaches are clearly inadequate to address this
challenge and others. The aggregate consequences of
this failure to capitalize on existing knowledge for the
interpretation of genome-scale experimental results is a
substantial reduction in the efficiency of the biomedical
research enterprise writ large, delaying the development
of both key insights and new therapies. The ability to
query many independent biological databases using a
common, community-driven semantic model would fa-
cilitate deeper integration and more effective utilization
of these diverse and rapidly growing resources.
Attempts to access and integrate data from multiple
public biomedical databases are often plagued with issuestral. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
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syncratic file formats, data redundancy, numerous inde-
pendent identifiers, and differing curation standards
and practices. While researchers’ decisions about which
databases and which data to use should be based on their
task and on biomedical criteria, they are often based in-
stead on logistical criteria such as the underlying database
representations, the ease or difficulty of accessing the data,
and the ability to integrate a given data set with others.
Researchers need an environment not only in which these
data are readily accessible but also where they can ask
queries that are biological in nature and unencumbered
from the underlying shape or format of the data.
Goble and Stevens [2] have written of several serious
issues in need of addressing for biomedical data integra-
tion, including the need for shared identities and seman-
tics, the need to use existing standards where available,
and balancing data collection with data use; they state
that these problems have led to a current “loose feder-
ation of bio-nations”. While work to integrate various data
is progressing, Good and Wilkinson point out that we
are seeing “‘semantic creep’—timid, piecemeal and ad
hoc adoption of parts of standards” [3]. Linking data
across resources is necessary for building integrated sys-
tems; however, linking the data without understanding the
semantics of those links merely generates more data [4].
Furthermore, any data integration must be able to support
multiple modes of reasoning that can deal with the fact
that integrated data are likely to have noise and errors [5].
While many domains have developed standard file for-
mats for the consistent sharing of data, these formats
are generally domain- or task- specific, making them dif-
ficult to integrate with one another. Other existing non-
ontologically grounded approaches to data integration
include maintaining cross references that point to re-
lated identifiers and records in other sources but often
conflate semantics, e.g., by linking a protein record to a
gene record (such as some mappings provided in large
curated databases). Other linked data approaches typic-
ally have weak semantic abstractions that do not map
to a single common biomedical model and do not un-
ambiguously assert which biomedical entities are seman-
tically identical across data sources. This is a serious
hindrance, as Goble and Stevens have posited: ′The failure
to address identity will be the most likely obstacle that
will stop mashups, or any other technology or strategy, be-
coming an effective integration mechanism” [2]. Ontology-
based approaches to data integration thus far have been
either small or focused on specific domains or tasks.
Larger semantic integrations have not provided declara-
tive representations of mappings, or use non-standard
semantic models. Despite decades of effort, the goal of
integrating diverse data into a common biomedical model
remains elusive.We have put together a set of five methods, some novel
and some that build on prior work of others, that over-
come problems commonly encountered when attempting
to semantically integrate information from multiple data
sources, When applied collectively these methods resolve
seven key problems. (1) varying identifiers used across
data sources to refer to the same concepts; (2) differing
file formats using different lexicalizations and interpreta-
tions of identifiers; (3) conflation of informational entities
(e.g., identifiers and records) with biomedical concepts
(e.g., genes and gene products, processes and interactions);
(4) the use of varying non-ontologically grounded seman-
tic models; (5) errors and inconsistency among source
data; (6) instability of identifiers and URIs over time in in-
tegrated resources; and (7) difficulty in tracing and report-
ing provenance of integrated data.
We demonstrate these solutions by presenting KaBOB
(the Knowledge Base of Biomedicine), a system that inte-
grates 18 sources of biomedical data using 14 prominent
Open Biomedical Ontologies (OBOs) as a foundation and
vocabulary for modeling, thus facilitating interaction with
the wealth of existing data and tools that already rely on
these OBOs. In KaBOB, identity across data sources is
maintained through the generation of a single biomedical
entity for each set of data-source-specific identifiers each
referring to the entity. These entities, along with the OBO
concepts, function as the building blocks for the common
biomedical representations, which can be simultaneously
modeled and thus queried at multiple levels of abstraction.
KaBOB maintains a clear distinction between source data
and biomedical concepts and represents both explicitly.
Users need only understand the common OBO-based rep-
resentations to interact with data from all of the integrated
sources that have been mapped into the biomedical rep-
resentation, rather than having to know each relevant
source’s specific modeling and the similarities and differ-
ences among each data model; however, for data that have
not been mapped to biomedical concepts, the source data
are also available for querying over a common informa-
tional metamodel. KaBOB uses declaratively represented
forward-chaining rules to map from the source data to
biomedical concepts, and the explicit representation of
both the source data and the rules together provide trans-
parent and computable provenance for every concept and
assertion. By resolving many of the issues that routinely
plague biomedical researchers intending to work with data
from multiple data sources simultaneously, KaBOB pro-
vides a platform for ongoing data integration and develop-
ment and for formal reasoning over a wealth of integrated
biomedical data.
Methods
Biomedical data sources tend to use various idiosyncratic
data models that often do not integrate well with each
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quently, there is no immediately straightforward way to
combine their data. To build KaBOB we tackle the
problem of mapping data source contents to a common
biomedical model incrementally. First we explicitly rep-
resent the contents of the data sources as informational
constructs (e.g., records, identifiers), then apply declarative
rules to create representations of the biomedical entities
they denote, grounded in a common model that is
based on the OBOs. This division of information entities
and biomedical concepts is one of the fundamental ideas
underlying KaBOB. It greatly simplifies the manner in
which biomedical representations are created and edited,
as well as provides several additional advantages: for ex-
ample, functioning as provenance. Furthermore it easily
allows multiple representations of the source data to be
generated, for example at differing levels of granularity or
generalization, all still coherent with the overall model.
Since each step in KaBOB construction is separate and in-
cremental they can be developed and debugged independ-
ently, by teams of developers with differing skill sets. For
example, the KaBOB approach separates computational
systems design decisions (e.g., how to read multiple file
formats) from ontological decisions related to biomedical
model representation, processes that are intermingled in
other approaches.
We use five methodological steps to solve major prob-
lems commonly encountered in semantic data integration.
(1) Data source records are explicitly represented using a
common informational model. (2) References to identi-
fiers in these records are canonicalized. (3) Identifier
mappings across data sources are used to derive sets of
IDs that are intended to refer to the same biomedical
concept, and (4) these identifier sets and a correspond-
ing biomedical entity for each are explicitly repre-
sented. Finally, (5) forward-chaining rules are used to
produce representations that are grounded in common
biomedical models in the form of prominent OBOs that
build upon the unified biomedical entities. This model-
ing is done in such a way as to avoid conflicts in the
event of inconsistent underlying data. Each step is dis-
cussed individually, in the context of applying them
collectively to produce KaBOB.Figure 1 KaBOB Construction. Depicts the incremental construction of KaB
outputs. Construction starts with downloading files and flows through tran
more RDF. Steps marked with ** involve multiple sets of rules being run anKaBOB has three major subdivisions of representation:
(1) an imported collection of prominent OBOs that serve
as the representational foundation for the rest of the
knowledge base; (2) the representation of source database
records, schemas, and identifiers, modeled as instances of
information content entities (extended from the Informa-
tion Artifact Ontology [6]), collectively referred to as the
ICE content of the knowledge base,; and (3) the represen-
tation of biomedical concepts such as biological processes
and interactions, diseases and phenotypes, and genes,
gene products, and other types of biological sequences
(extended from OBOs such as the Gene Ontology [7] and
the Sequence Ontology [8]), collectively referred to as the
BIO content of the knowledge base.
Figure 1 depicts how KaBOB is constructed. KaBOB,
initially an empty triplestore, is built up incrementally.
First, ontologies are downloaded and then loaded dir-
ectly into the triplestore. Database source files are down-
loaded and converted to RDF; the resultant RDF triples
are loaded into the ICE section of KaBOB. Forward-
chaining rules (OWL- > ICE) generate ICE identifiers for
each of the biomedical concepts in the ontologies.
(These additional identifiers are required since in our
representation records will only contain URIs for identi-
fiers not URIs for biomedical concepts themselves,
making the ICE-BIO distinction unambiguous). The
second set of forward-chaining rules generates identity
links between ICE identifiers, specifically, assertions of
skos:exactMatch links between identifiers denoting
the same biomedical concepts. The next step instanti-
ates an ID set in the ICE side of KaBOB corresponding
to each unique biomedical concept. Each biomedical
concept is then explicitly represented in the BIO section;
for example, a gene entity on the BIO side is created for
each such set of gene IDs. (This is the first real connection
from the ICE section to the BIO section). More forward-
chaining rules are then used to create (on the BIO side)
other biomedical concepts and assertions referred to
within the data source records, e.g., interaction events with
protein participants from protein-protein interaction data-
base records, processes with participating entities from
Gene Ontology annotations, and links from drugs to
genes or gene products from drug-related data sources.OB. Labeled arrows represent processes that flow from inputs to
slating them into RDF and then iteratively querying and producing
d their output loaded in sequence.
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has been loaded into the BIO side, KaBOB is ready to be
queried and used. Each of the steps required to build an
instance of a KaBOB knowledge base is discussed in
greater detail in the following subsections. A detailed list
of the steps used to build KaBOB is provided in Additional
file 1.
Sources
The initial release of KaBOB has been designed to in-
clude a wide variety of biomedical data from a number
of prominent publicly available sources. These data range
from attributes of core biomedical entities (e.g., genes,
proteins) to interactions between these entities (e.g.,
protein-protein interactions, gene/transcription-factor
interactions) to biological functions attributed to the en-
tities (e.g., Gene Ontology annotations). KaBOB is designed
to be extensible; as such, the list of data sources should not
be considered exhaustive or limiting. New data sources are
being added as needed to accomplish specific reasoning
and querying tasks.
KaBOB currently imports the following 14 ontologies:
1. Basic Formal Ontology (BFO) [9]
2. BRENDA Tissue / Enzyme Source (BTO) [10]
3. Chemical Entities of Biological Interest (ChEBI) [11]
4. Cell Type Ontology (CL) [12]
5. Gene Ontology including biological process, molecular
function, and cellular component (GO) [7]
6. Information Artifact Ontology (IAO) [6]
7. Protein-Protein Interaction Ontology (MI) [13]
8. Mammalian Phenotype Ontology (MP) [14]
9. NCBI Taxonomy [15]
10. Ontology for Biomedical Investigation (OBI) [16]
11. Protein Modification (MOD) [17]
12. Protein Ontology (PR) [18]
13. Relation Ontology (RO) [19]
14. Sequence Ontology (SO) [8]
KaBOB currently imports data from the following 18
data sources:
1. Database of Interacting Proteins (DIP) [20]
2. DrugBank [21]
3. Genetic Association Database (GAD) [22]
4. UniProt Gene Ontology Annotation (GOA) [23]
5. HUGO Gene Nomenclature Committee (HGNC) [24]
6. HomoloGene [25]
7. Human Protein Reference Database (HPRD) [26]
8. InterPro [27]
9. iRefWeb [28]
10. Mouse Genome Informatics (MGI) [29]
11. miRBase [30]
12. NCBI Gene [31]13. Online Mendelian Inheritance in Man (OMIM) [32]
14. PharmGKB [33]
15. Reactome [34]
16. Rat Genome Database (RGD) [35]
17. Transfac [36]
18. UniProt [37]
The utility of KaBOB is predicated not only on the
knowledge it contains but also by how up-to-date this
knowledge is. We have eased this knowledge acquisition
process by automatically downloading individual data
sources from their corresponding locations on the Inter-
net and constructing file parsers that can detect changes
in data source file formats and report back if the parsers
need to be updated. Logs are kept for every download
recording the date and location of each source file, and
logs are generated for every file parse recording warn-
ings and errors that need to be addressed. The entire
process from download to final knowledge base creation
can be accomplished in under 2 days, allowing KaBOB
to be updated at the same frequency as the major data
sources it depends on. Changes to the format of the data
sources can require modifications to the file parsers,
which is relatively straightforward, but does require some
time, typically about a day. Efficient storage of and access
to historic copies of all ICE data is being investigated (see
Future Work).
Database record representation
All database content is directly modeled as information
content entities (ICEs) as defined in the Information
Artifact Ontology, one of the Open Biomedical Ontologies
[6]. An initial model for the database record representa-
tion is discussed in detail in a previous publication [38].
Briefly, each database, schema, record, field, and field
value is modeled as an ICE. The obo:has_part relation
is used to connect record ICEs to their corresponding field
value ICEs and database schema ICEs to component field
ICEs, while the kiao:has_template relation is used
to link record ICEs to their corresponding schema ICEs
and field value ICEs to corresponding field ICEs. The sim-
plicity and generality of this record representation permits
its use toward the many different data sources being in-
corporated into KaBOB, regardless of the underlying file
format (e.g., CSV, XML). An example of this representa-
tion can be seen in the ICE panel (left side) of Figure 2.
This figure in part depicts two simplified Gene Ontology
annotation records (record1 and record2), which are each
connected to two field values, one a UniProt ID and one a
GO ID. Note that since both source records use the same
GO ID, these two record ICEs use the same field value
ICE instance (fieldvalue4); each such reuse of a field value
ICE instance keeps the three triples required to define it
from being redundantly represented in the knowledge
Figure 2 Example ICE Records and corresponding BIO Concepts. Depicts an excerpt of the knowledge representation in KaBOB. Ovals are used
to depict instances, and rectangles classes. Single line arrows represent triples and point from their subject to their object and are labeled with
their property. The iao:denotes links that cross from the ICE to the BIO side are emphasized with dashed arrows. The double arrows are shorthand
for representing an owl:Restriction on the given property with some values from the object value. This figure depicts two GO annotation records that
are then converted to biomedical concepts using the same rule (rule not depicted). Additionally sets of gene identifiers are also depicted that denote
their corresponding gene concept. On the BIO side the relations between genes, proteins, and gene or gene product aggregate classes are also
shown. Other than the records and their field values, generated by the file parsers, all other links are the output of applying rules.
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use of field values results in a large reduction in the total
number of triples required to represent the ICEs. For the
NCBI Gene Info file this amounts to an approximate 44%
reduction in the number of required triples. Each field
value is linked to an associated template that indicates the
field for which it serves as a value (e.g., in a CSV file this
would be the column name), since fieldvalue3 and vieldva-
lue5 are values of the same field, they point to the same
field ICE instance. Each field is connected to its corre-
sponding value.
The record representation used by KaBOB differs from
the previously published representation of Bada et al.
[38] by being more record-centric. We now allow records
to share structure with other records, for example to share
field value instances such as in the aforementioned ex-
ample, greatly reducing the number of triples required. A
minor difference between the current and former repre-
sentations is that record ICE instances are now linked
via obo:has_part to field value ICE instances in
KaBOB, whereas field value ICE instances were linked
via obo:part_of to record ICE instances in the former
representation of data source records.
The use of the SHA-1 hash enables the ICE URIs to
be deterministically generated and reused whenever a
field with the identical value is encountered without the
need to keep track of field values previously encountered
during construction. This also provides consistency across
KaBOB instance builds, which aids in checking for differ-
ences and debugging. For example, when specifying theURI for an NCBI Gene database taxonomy field with
value 9606, our optimization uses the SHA-1 hash
function [39] over the field value (“NCBITaxon:9606” in




Canonicalization of identifiers in records
While we attempt to generate records that are as faithful
to the source representation as possible, we do modify
the records by transforming identifier strings to canoni-
calized URIs. For example, the NCBI Gene identifier for
the human ATP5D gene is rendered in source records as
“EG513”, “EG_513”, “EG:513”, “513” (in a field designated to
contain identifiers from the NCBI Gene database), etc., all of
which would be canonicalized to the same URI for that
NCBI Gene identifier, i.e., http://kabob.ucdenver.
edu/iao/eg/EG_513_ICE.
Forward-chaining rules
Assertions in KaBOB are generated using a series of de-
claratively represented forward-chaining rules. These rules
take information that is variably encoded among the re-
cords of the disparate source databases and create RDF
assertions uniformly represented in terms of prominent
OBOs. There are several batches of forward-chaining
rules, as depicted in Figure 1, and the triples generated
by the rules are saved in compressed N-Triple files and
then loaded into the KaBOB triplestore.
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the example in Figure 2, where some of the symbol
names have been simplified for readability. (A full version
of this rule is provided in Additional file 2). This rule
queries record ICEs imported from the Gene Ontology
Annotation database [23] to retrieve UniProt ID ICEs and
GO biological process ID ICEs. It uses the triples linking
ID ICEs to biomedical concepts (via the iao:denotes
relation) to retrieve the corresponding protein class for
the protein ID and the corresponding biological process
for the GO ID using the following graph pattern.
The rule then uses the following template (depicted here
in Turtle RDF format) to construct additional triples.
These five triples specify a new process class, formally
defined as a subclass of the given GO process with a re-
striction that the given protein is a participant in the
process. This new class captures the “all-some” seman-
tics of a GO biological process annotation, describing
the subclass of the biological process such that for each
instance of that subclass there exists some instance of
the specified protein that participates in that process
[40]. It uses existing known values for ?protein and
?goProcess retrieved as bindings by the body of the
forward-chaining rule, and it creates new URIs for the
restriction ?participant and the dynamically gener-
ated ?newProcess class. Figure 2 shows an example
of the input and output to such a rule. The rule would
be run for record1 and record2, it would get the protein
ID value of the UniProt ID field, and the GO ID value
of the GO ID field in each of these records, then get
the denoted concepts (i.e., the corresponding protein
and biological process classes) by following the dotted
lines into the BIO representation (Figure 2, BIO panel,
right side). Then, new classes of biomedical concepts
would be dynamically generated (BIO11 and BIO12)
and connections made to existing biomedical concepts.
In this case, each would be made a subclass of the GO
process specified in the original GO annotations (oxidativephosphorylation) and a subclass of a restriction specifying
the given protein as a participant in the process.
The rules are represented using a domain-specific lan-
guage written using Clojure s-expressions. It is an exten-
sion of the pattern language provided in the open-source
KR Clojure library [41]. The rules are applied using a
straightforward implementation of a forward chainer in
Clojure. The rules could also be serialized to other formats.
SWRL [42] is an obvious potential target; however, SWRL
rules cannot have unbound variables in the head, thus
blocking reification, which is needed for many (though
not all) rules. The rules could be realized as SPARQL
CONSTRUCT queries as well. This avenue has not been
explored in great detail, as SPARQL 1.1 was still in its in-
fancy and access to the functions necessary to reify new
entities was extremely limited at the time of the start of
the KaBOB project. This can be reinvestigated as future
work, along with providing RIF (Rule Interchange Format)
[43] export and import of rules. A complete example of a
rule and more discussion is provided in Additional file 2.
Identifiers and identifier sets
Since different data sources use different identifiers to
refer to the same given concept, aggregating data across
sources requires managing sets of identifiers that are
intended to refer to the same concepts. In KaBOB, identifier
sets are built incrementally. First, mappings between identi-
fiers mentioned in the underlying data sources are extracted
and explicitly represented. Then, unified identifier sets are
derived from all relevant extracted mappings. A correspond-
ing biomedical entity is created for each identifier set, e.g., a
protein for a given set of protein IDs that refer to this pro-
tein. We do this work in a series of stages, allowing the out-
put of each stage to be used on its own as well as enabling
the results to be easily inspected and debugged, as identifier
mappings in individual data sources can be idiosyncratic
and occasionally incorrect. These data further serves as
provenance for how the biomedical entities are created.
Identifier mapping idiosyncrasies can arise from infor-
mation in data sources being represented at varying levels
of abstractions and granularity, requiring additional effort
to understand and disambiguate the identifier mappings
that they provide. For example, data sources, such as
NCBI Gene Info [31], often use a field called “database
cross-reference” (or “dbXref”) that may have mappings
to different types of things, e.g., related drugs, diseases,
pathways. Care must be taken when navigating these
fields to prevent links from being constructed between
identifiers that are not actually semantically exact matches,
e.g., between drugs and diseases, or between genes and
proteins. In order to be able to sift through the seman-
tic ambiguities in cross-referencing fields, a step was
introduced to help identify the cross-referencing intent.
Identifying the intent of a cross-reference field requires
Livingston et al. BMC Bioinformatics  (2015) 16:126 Page 7 of 21knowing something about what a given identifier will
ultimately refer to; however, at this stage in KaBOB
construction entities are not fully represented. This cir-
cular logic was overcome by bootstrapping the KaBOB
construction process with simple type information of
what will be the ultimate resulting entities. Rules were
created to generate this information and break the cycle.
These entity typing rules connect IDs from data sources
to corresponding biomedical classes (subclasses of which
will be ultimately created); for example, all NCBI Gene
IDs are asserted to refer to types of DNA (pointing to the
DNA class of the OBO Sequence Ontology) using kiao:
denotesSubClassOf, a macrorelation for the property
chain of iao:denotes and rdfs:subClassOf. (That
is, a kiao:denotesSubClassOf assertion of the form
X kiao:denotesSubClassOf Z entails the two triples
X iao:denotes Y and Y rdfs:subClassOf Z.). After
these denotesSubClassOf assertions are created, a
second set of ICE-to-ICE rules use these assertions to ex-
tract only those mappings between ICE IDs from the vari-
ous data sources (e.g., the UniProt ID mappings file [37])
that denote semantically identical entities. For example, so
as to extract only the mapped IDs stored in the dbXref
field of a given NCBI Gene Info record that are denota-
tionally semantically equivalent (i.e., that denote the
same entity as that denoted by the NCBI Gene ID), the
executed rules pick out only those IDs that kiao:
denotesSubClassOf SO:DNA, as the entities denoted
by the IDs that do not satisfy this criterion are not
DNA sequences and are therefore unlikely to be the
same entity denoted by the NCBI Gene ID. Filtering
mapped IDs by making use of our explicit linkages of
ID types to types of biomedical concepts is a prag-
matic solution that is both effective and efficient. The
output of these identifier-mapping rules are skos:
exactMatch links between ID ICEs.
Great care is taken to not link things across type. For
example, even though the protein denoted by the identi-
fier UniProt:P30049 (ATP synthase subunit delta, mito-
chondrial) is coded by the gene denoted by the identifier
HGNC:837 (ATP5D), they are not linked with an skos:
exactMatch relation, because they do not refer to pre-
cisely the same concept, in that the former denotes a
class of proteins and the latter a class of genes. On the
other hand, a skos:exactMatch link is created between
HGNC:837 and EG:513, as they denote the same gene.
(Proteins are connected to the genes that code for them by
subsequent rules in the construction of the BIO portion of
KaBOB). The kiao:denotesSubClassOf assertions
are essential to sorting this out. A simplified example of
this type of representation can be seen in Figure 2: On the
ICE side are pairs of gene identifiers that refer to the
same genes on the BIO side, i.e., HGNC_837_ICE and
EG_513_ICE, which both denote Gene6, and HGNC_9604_ICE and EG_5742_ICE, which both denote Gene9.
Note that the gene identifiers denoting the same genes are
linked to each other via the skos:exactMatch relation;
however, there is no asserted relationship between corre-
sponding protein identifiers and gene identifiers on the ICE
side (e.g., between UniProt_P30049_ICE and EG_513_ICE),
only a relation between the denoted protein (Protein7) and
corresponding gene (Gene6) on the BIO side.
After the skos:exactMatch links are created, their
transitive closure is computed using the union-find algo-
rithm [44]. The union-find algorithm is an efficient method
for building a collection of disjoint (non-overlapping) sets
given a list of pairs of members that are in the same set. It
incrementally builds and merges sets of connected compo-
nents as it streams through the list of pairs. An explicit
identifier set is then created for each set of ICE identifiers
with a URI based on an SHA-1 hash of the sorted mem-
bers of the set. The use of a hashing function in this man-
ner allows the identifiers to be computed consistently over
time, which ensures that two KaBOB instances computed
from the same sources produce the same identifiers. (Like
using UUIDs, hashed URIs have no dependency on each
other and can be computed in parallel, unlike sequential
identifiers, e.g., set1, set2, …). The computation of this tran-
sitive closure, along with constructing the initial ICE RDF,
are the only parts of KaBOB construction not performed
using the forward-chaining rule system. It is possible to
compute this transitive closure with forward-chaining rules;
however, the union-find algorithm is extremely efficient,
with a running time of O(log*n), compared to potentially
needing multiple passes with forward chaining to compute.
As an example of computing and creating a set of iden-
tifiers each denoting the same biomedical concept, we
start with the following three triples, which specify map-
pings between IDs denoting the same gene.
After passing through the union-find algorithm the four
identifiers in these triples are grouped into a single identi-
fier set. The following four triples (in Turtle RDF syntax)
specify this set, which is given the URI kiao:KaBOB-
ID-Set-qn-3e2r15NYu8WUNe-a2BXB_nZ, based on
the SHA-1 hash of its members. The set is comprised of
four identifiers whose membership is the set is asserted
via the kro:hasMember relation:
Representation of biomedical concepts
More rules are used to build up biomedical representations.
First, a biomedical concept is created for each identifier set,
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ing the given gene. Layers of biomedical sequence abstrac-
tions (discussed in the Representation at Multiple Levels
of Abstraction subsection of the Discussion section) are
added, e.g., aggregate gene-or-gene-product classes and
gene-or-gene-product-or-variant classes. Connections are
made between corresponding genes and gene products,
e.g., representing that a given gene serves as the indir-
ect template for a given protein, and connecting that
protein to the corresponding gene-or-gene-product ag-
gregate classes.
The last set of rules continue to convert information
variably represented in the ICE records into unified bio-
medical representations in terms of relevant OBO classes.
Generally, each KaBOB assertion derived from a source
database requires one rule and results in at least one dy-
namically generated subclass to model the assertion in
OWL. A rough estimate is one rule per field in the source
records; however, some fields require multiple rules. For
example, the gene type field in the NCBI Gene database
requires one rule per possible sequence type (e.g., protein-
coding gene, noncoding gene, pseudogene) to accurately
model the value of the field, as these values are curated
by NCBI using a small custom controlled vocabulary,
each term of which is uniquely mapped to a Sequence
Ontology class. On the other hand, extracting other types
of assertions requires looking at multiple fields in one rule.
For example, extracting a drug-gene association assertion
from PharmGKB requires the examination of four fields,
as PharmGKB uses two fields to specify the identifiers of
the interacting entities and two more fields to specify the
types of these entities (e.g., gene, drug).
As an example of a dynamically rule-generated biomedical
concept extended from existing OBO concepts, the following
nine triples (in Turtle RDF syntax) represent the interaction
(obo:MI_0000) between the drug isoflurane (kbio:BIO_
e7687a66889760a757dd0bdc6b12ea67) and the
gene ATP5D (or one of its products or variants) (kbio:
GorGPorV_BIO_8b130947230c6d1bdb2a067cba251
4de), derived from the Drugbank database [21] :
The first block of triples models the OWL restric-
tion class (kbio:R_I4hmhKlPj3PLuD__6T2QucrTfWk)representing the class of all things in which the gene ATP5D
or one of its products or variants participates. The second
analogously models a restriction class (kbio:R_mSPMJTg
Ch1qGqP7t_SNOf1KF-Kk) of all things in which isoflur-
ane participates. The third block formally defines a class
(kbio:I_IB7hiBNOSmq0zEGYg6D7NXd9kQ0) as the
subclass of both of these restriction classes and an OBO
interaction class, i.e., the subclass of interactions such that
for each of its members, there exists some isoflurane that is
a participant, and there exists some ATP5D or one of its
products or variants that is a participant.
A large amount of redundant generation of semantically
equivalent OWL Restriction classes is avoided through the
use of assertions that generate unique hashes for the re-
strictions. For example, the URI for the restriction
kbio:R_I4hmhKlPj3PLuD__6T2QucrTfWk is gen-
erated from a SHA-1 hash of the property and object
values of the triples used to define it. Reusing OWL
fragments like this significantly reduces the number of
triples and in doing so reduces the load on reasoners
that will eventually operate over KaBOB.
Currently there are 75 rules. Depending on the com-
plexity of the rule, and if other rules that look at similar
source records or that have similar output representa-
tions exist, a new rule can be written in anywhere from
minutes (if it is closer to a cut and paste) to an hour or
so (if more thought and exploration is required).
Implementation
Command-line build scripts for installations in both
AllegroGraph (v4.14) [45] (a state-of-the-art commercial
triplestore provided by Franz Inc.) and Virtuoso (v7)
[46] (an open-source triplestore based on relational data-
bases provided by OpenLink Software) are provided in
the open-source release. We run these scripts via a Hud-
son server in order to monitor performance and output;
however, they could be run just as easily without Hud-
son. While we have targeted AllegroGraph and Virtuoso,
there is nothing specific about KaBOB to either. To
query the triplestore, the rule engine and identifier-set
creation code uses the open-source KR Clojure library,
which can talk to any triplestore that speaks Sesame or
Jena. At most, one small function for establishing the
connection to the source triplestore would have to be
extended, but more than likely speaking to a different
server requires only changing the parameters for server
location and authentication. The build scripts would
have to be extended for additional triplestores to provide
a command-line call for loading a directory of RDF files
into the triple store. Porting the scripts from Allegro-
Graph to Virtuoso was done in about a day. The
command-line scripts are written in BASH, and all other
code is Java or Clojure (a Lisp dialect that runs on the
JVM), both configured with Maven, allowing the code to
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work on a custom-built machine with 24 cores, 96 GB
RAM, 2 TB of SSD drives LVM RAID-0 (for the OS and
triplestore), and 3.6 TB of spinning disk RAID (for man-
aging the RDF files), running Fedora v17.
Results
Two fully functional versions of KaBOB have been built,
along with one partial version. One fully functional version
has been built using only human source data and another
using human data plus data for seven major eukaryotic
model organisms (listed along with their NCBI Taxonomy
IDs): Mus musculus (10090), Rattus norvegicus (10116),
Drosophila melanogaster (7227), Saccharomyces cerevisiae
(4932), Caenorhabditis elegans (6239), Danio rerio (7955),
and Arabidopsis thaliana (3702). (Data for subtaxa of these
taxa also represented in the NCBI Taxonomy, e.g., subspe-
cies of mice and strains of yeast, have been included.)
Ideally, a version of KaBOB would be built using data for
every organism included in the data sources; however, that
is out of reach of our current hardware/software configur-
ation (see discussion in the Current Limitations and Future
Work section). For the all-organism version, only the ICE
records have been produced. For the two fully functional
versions, all KaBOB steps are performed, from initial
ICE record representation to running of all of the BIO
concept generating rules. Each version can be built in
approximately two days.
Data is parsed from a total of 43 different files from 18
data sources. Table 1 shows the numbers of triples and
compressed file sizes for the three versions of KaBOB
and for these versions in total as well as for the three
primary triple subsets of imported OBOs, ICEs of original
source data, and rule-generated data. All versions of
KaBOB use the same 14 ontology files, which amount
to 13,830,676 triples. The triple subsets of imported OBO
content and RDFized original source data are the two
primary sources of data to KaBOB and are shown in
the two parallel paths on the left side of Figure 1. The
rule-generated data comprise all other triples in KaBOB
and includes all of the RDF files depicted under theTable 1 Size of KaBOB
imported OBOs ICE records
subset # triples size .owl (GB) # triples size .nt.
human only 13,830,676 1.5 144,489,737 2.0
human +7 major
model organisms
13,830,676 1.5 369,027,022 4.9
all organisms 13,830,676 1.5 9,584,033,541 126
Lists the size of the various collection of RDF generated in the KaBOB build process
include the imported OBOs, the ICE records (output of the file parsers), and the gen
sum of the first three. The rows represent subsets of the KaBOB data based on orga
organisms (listed in the paper), and the final row is for all organisms combined. DuKaBOB block in Figure 1. Table 2 shows the number of
identifier sets in each version of KaBOB, along with the
number of triples required to represent those sets, and
the size of those triples in compressed N-triple format.
The ability to answer complex queries that target the
common OBO-based biomedical model is demonstrated
by a series of example queries. An extended use case is
discussed in the “Following up on GSEA results; a case
study for using KaBOB” section, and several other exam-
ples are provided in Additional file 3.
This project has also produced or substantially expanded
three open-source software libraries. First, this project was
the primary motivation for the already released KR library
for working with RDF and SPARQL in Clojure [41], which
has been downloaded more than 800 times. In addition,
timed with the publication of this paper is the release of
two more libraries of code. The first is a Java-based project
consisting of the file parsers for all of the data sources serv-
ing as input into KaBOB and code to convert the parsed
files into RDF. The second project released in conjunction
with this paper is the KaBOB-specific code itself. This code
includes the scripts for building KaBOB, as well as the ID
set merging code and all of the declarative rules.
In addition to building an integrated system that in-
creases the value of the data from the underlying sources,
we are also able to detect potential errors in the data
sources and report them to their curators. Errors can be
detected by querying KaBOB for assertions that should
not exist, e.g., a protein asserted to exist in two disjoint or-
ganismal taxa. In this way, we were able to find a mapping
in DIP that erroneously equated a mouse protein to the
homologous rat protein, an error that was replicated in
the iRefWeb aggregation. During the identifier-merging
step, we have also looked for collapses of what should be
multiple entities into single entities. This has revealed er-
rors in our own code, such as bugs in the ID canonicaliza-
tion inadvertently truncating IDs and causing them to
collide, as well as revealing bad mappings in the under-
lying data sources, including finding over 300 cases in
DrugBank where multiple DrugBank records mapped to
the same external identifier. Pipelined approaches to usinggenerated (rules and id sets) KaBOB total
gzip (GB) # triples size .nt.gzip (GB) # triples size (GB)
7,615,547 0.2 165,935,960 3.6
34,968,305 0.7 417,826,003 7.1
n/a n/a n/a n/a
, recorded in number of triples and size on disk. The first three major columns
erated triples (output of the rules and ID merging). The fourth column is the
nisms included. The subsets are human-only, human plus seven major model
e to the scale of the data in the final subset this data is currently incomplete.
Table 2 Number of entities / ID sets
subset # id sets # id set triples total RDF .nt.gz file size
human only 336,472 952,807 14 MB
human +7 major model organisms 1,513,932 3,644,255 56 MB
List the number of entities or ID sets in each subset of KaBOB. Each ID set is the collection of identifiers from multiple data sources that are intended to denote
the same biomedical concept. Number of ID sets, number of triples, and size on disk is reported.
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such errors, as they would blindly hop through whatever
mappings are being used to the target ID, potentially
producing erroneous mappings. See Additional files 4
and 5 for a more detailed discussion of queries used to
find errors, and a more complete explanation of the
DrugBank example.
Discussion
In this section we discuss the solutions to data integra-
tion problems that our methods overcome, and how they
are manifested in KaBOB. We also provide a detailed
example of querying KaBOB using SPARQL 1.1 and con-
clude with a discussion of limitations and future work.
Solutions to data integration problems
The methods and knowledge representations that we
have developed to integrate multiple data sources into a
unified knowledge base provide solutions to seven seman-
tic data integration problems. These solutions include: (1)
distinct representations of data and biomedical concepts;
(2) common biomedical representations; (3) identity reso-
lution across data sources; (4) consistency despite poten-
tial errors or contradictions in source data; (5) the ability
to represent and query data using multiple different levels
of abstraction or granularity simultaneously; (6) stable and
reusable URIs; and (7) traceable provenance.
Distinct informational entities and biomedical concepts
Previous work integrating large quantities of biomedical
data either use source-specific modeling and thus are ac-
tually disjoint, or do not include the portions of the
source data that have not yet been represented in the
common biomedical model (see discussion in Related
Work). Another common problem when dealing with
biomedical data is overloading the meaning of common
identifiers (e.g., using a UniProt identifier to simultan-
eously represent an identifier, a record, and a protein).
KaBOB resolves these problems by clearly modeling both
biomedical concepts (e.g., genes and gene products, dis-
eases and phenotypes, interactions and processes) and
informational entities referring to these concepts (e.g.,
database schemas, records, fields, field values, and iden-
tifiers) and maintaining an explicit distinction between
the two categories. For example, KaBOB has distinct,
explicitly represented concepts for a UniProt identifier,the corresponding UniProt record, and the class of protein
that the identifier denotes and the record describes.
All of the aforementioned informational entities of the
source databases are represented as information content
entities on the ICE side of KaBOB. Biomedical represen-
tations are derived from these ICE data and represented
on the BIO side of KaBOB. (These representations are
further discussed in the next subsection). The only links
that cross the demarcation between ICE and BIO repre-
sentations are relations that indicate that a given informa-
tional entity on the ICE side “is about” some biomedical
concept on the BIO side. There are three relations from
the IAO that are used to make these connections: iao:
denotes is the most frequently used one, indicating that
a given ICE exists for the sole purpose of identifying a
given BIO concept (e.g., UniProt:Q3B891 denotes the hu-
man BRCA1 protein); iao:mentions is a weaker rela-
tion stating some part of the ICE denotes the BIO concept
(e.g., a given sentence mentioning the human BRCA1 pro-
tein ); and iao:is_about is the parent relation of the
two, encompassing a more general sense of aboutness.
The vast majority of these ICE-to-BIO links are iao:
denotes assertions that are generated to link identi-
fiers to their denoted concepts. Rules can also assert an
iao:mentions link between a record from which
information was retrieved to the BIO class that was dy-
namically created in order to represent that the class
was based on information in that record. These links
across the ICE-BIO divide serve as a primary source of
identifying provenance data for biomedical concepts.
The clear separation and explicit representation of
source data and biomedical concepts provide several dis-
tinct advantages. The availability of a common biomedical
model allows queries to be written in terms of biomedical
concepts, not in terms of information artifacts or database
structures with which the user must become familiar, and
queries over the biomedical modeling will not have to
change if new source information is mapped to existing
biomedical concepts and assertions. Source information
that has not yet been mapped to biomedical-concept-
based representations can still be queried given that it is
first represented as information content entities on the
ICE side. Furthermore, explicitly representing the source
data makes it available as provenance for the biomedical
representations, enabling queries of source evidence for
given biomedical assertions (discussed further below).
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KaBOB is modeled using representations from existing
prominent biomedical ontologies created and maintained
by core developers with significant community input.
We rely on prominent Open Biomedical Ontologies
(OBOs) as a framework. The species-specific biological
sequences and their information from source databases
that comprise KaBOB are placed within this framework.
When necessary we extend existing ontological classes
with dynamically generated composite classes (e.g., a
composite class representing the interaction of two
given proteins, defined in terms of already explicitly
represented classes for molecular interaction and for
the two proteins). These composite classes are for-
mally defined in terms of explicitly represented OBO
classes, carefully maintaining the OWL “all-some”
quantification among related classes. The large major-
ity of KaBOB assertions rely on relations from the Re-
lation Ontology (RO) [19], those used in the OBO
cross-products effort [47], and natural extensions of
the latter. All of the ICE representations in KaBOB are
types of information content entities that we have
modeled as extensions of the Information Artifact
Ontology (IAO) [38].
Our use of ontological concepts and relations already
explicitly represented along with the dynamically gen-
erated composite concepts formally defined in terms of
these existing concepts allows us to precisely capture
biomedical knowledge, including content of source da-
tabases, to arbitrary levels of complexity. Using and
extending prominent OBOs as a framework enables
sophisticated reasoning over the content of KaBOB.
Most straightforwardly, a plethora of deductive infer-
ences can be made based on the ontologies’ fundamen-
tal taxonomic hierarchies, non-taxonomic linkages among
their classes, and the formal definitions of the active OBO
cross-product efforts. This approach also opens the door
for research into inductive and abductive reasoning meth-
odologies. Furthermore, reliance on these OBOs facilitates
interaction with the enormous amount of data annotated
with them and with other resources making use of them.
This in turn makes it easier to model and absorb source
data into KaBOB as well as easier for users familiar with
the community ontologies to interact with KaBOB and to
formulate queries and understand their output. The repre-
sentations in KaBOB are biased to be event-centric, as
they are easier to represent with all-some restriction se-
mantics. However, entity-centric representations are cre-
ated for simplicity in some cases, e.g., assertions linking
proteins to the genes that code for them (though it would
also be possible to explicitly represent the implicit tran-
scription and translation events). Event-centric represen-
tations could be translated into entity-centric classes and
assertions; however, to conform to all-some assertionalsemantics, this requires a somewhat more roundabout
representation so that only the entity’s potential to partici-
pate in a particular event is represented as opposed to
stating that all instances of a given entity necessarily par-
ticipate in it.
Identity resolved across data sources
In order to integrate data from multiple data sources it
is essential to understand which identifiers across the
sources fundamentally refer to the same things. This is
complicated by the fact that data sources often use their
own source-specific identifiers to avoid external depend-
encies that could cause problems in their curation ef-
forts. Fortunately, mappings are often provided across
data sources. Sometimes these mappings provide one-
to-one mappings specifying identity; however, they are
often provided as more convoluted sets of “related”
identifiers. Great care must be taken when processing
these mappings (see the previous “Identifiers and Identi-
fier Sets” subsection).
In KaBOB, each identifier in a set, all of which denote
the same biomedical concept, is directly linked to this
single shared biomedical concept. We chose this ap-
proach as opposed to the alternative of modeling asser-
tions from each data source individually on the BIO side
of KaBOB and then connecting the BIO entities using
owl:sameAs assertions. The alternative is more opaque
and would be difficult to navigate for RDF approaches
that do not make inferences over owl:sameAs asser-
tions. Even for some systems that handle owl:sameAs
the alternative approach dramatically increases the num-
ber of triples and could result in intractability. Our
method of first generating an identifier set and then
linking to a single corresponding biomedical concept al-
leviates these problems. The identifier sets are also use-
ful in and of themselves when querying the data source
records without having to travel in and out of the bio-
medical representations.
By resolving identity across data sources, KaBOB alle-
viates one of the most critical [2], time-consuming, and
redundant steps [48] in integrating data from multiple
sources. Systems that do not do this require users to
maintain mappings across sources in every query, dra-
matically increasing the complexity of the query and cre-
ating ongoing maintenance problems. In KaBOB a set of
trusted high-quality mappings is applied first, and then
the unified entities are used to aggregate data from mul-
tiple data sources. Since the mappings are all managed
and extracted using explicitly represented sets of de-
clarative rules, it is easy to produce or maintain alterna-
tive mappings or to recompute the unified entities using
a different set of trusted sources in the event a user be-
lieves that a different set of sources should be used as
the basis for the mappings. This can be done by either
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generation. The subsequent steps to building KaBOB
would then proceed as normal, connecting representa-
tions to the alternate entities, and existing queries target-
ing the biomedical representations could still be issued
without the need to be altered. Resolving the identities of
data-source-specific identifiers, aggregating them into
sets, and linking them to biomedical concepts they de-
note in common is the essential foundation that en-
ables the querying of KaBOB in terms of the shared
biomedical modeling rather than having to perform
queries in terms of (often a series of ) data-source-
specific representations.
Tolerance for inconsistent source data
KaBOB tolerates inconsistencies in assertions among
disparate data source records on both the ICE and BIO
sides of the knowledge base. On the ICE side of KaBOB,
source data records are modeled as independent infor-
mational entities (specifically, records, fields, field values,
and identifiers). Conflicting assertions would each be in-
dependently represented as different records. This cap-
tures the fact that one of the assertions was made in its
corresponding record and the other assertion in the
other record, and these two assertions may be conflict-
ing or not if integrated. Note that our methodology also
alleviates the issue of assertional inconsistencies within a
given data source. While the semantics of conflicting as-
sertions within most of these data sources is ambiguous,
these assertions are modeled the same way as if from
separate data sources, with one assertion within one rec-
ord and the other assertion in the other record, all expli-
citly and clearly represented as informational entities.
Conflicting assertions extracted from conflicting source
records can also be modeled on the BIO side without
generating an inconsistency. This is enabled by generat-
ing dynamic subclasses for every assertion being mod-
eled in the BIO portion of the knowledge base. This
minimizes the places at which two assertions can con-
flict since each new assertion from a source database is
represented as a subclass. As such each assertion is es-
sentially in its own “world”, all contained in the KaBOB
open world. These sets of subclasses can then be aggre-
gated in multiple ways as discussed in the following
section, and demonstrated in the subsequent example
query. Since there is no guarantee that data from mul-
tiple sources, or even within one source, is necessarily
consistent (and in fact the converse is almost a given)
this is something that data integration systems, espe-
cially those using formal logics (e.g., OWL) must necessar-
ily address. Failure to do so could result in an inconsistent
(and unusable) or erroneous knowledge base. By modeling
representations with an extensive amount of subclas-
sing we create an environment where the inevitableinconsistent or erroneous assertion will not ultimately
result in an inconsistent knowledge base. By following
this precedent when new sources are added this envir-
onment is maintained, creating a stable environment
for the ongoing integration of data.
Representation at multiple levels of abstraction
For some tasks biologists care greatly about distinctions
between corresponding biological sequences, e.g., genes
versus gene products, reference sequences versus vari-
ants, species-specific sequences versus homologs; for
other tasks, the distinctions are unimportant and so
corresponding sequence types can be aggregated into
more collective types. KaBOB provides a flexible know-
ledge model capably of representing the full spectrum
of sequence type abstractions. Representations such as
the collective class of genes, gene products, and vari-
ants can provide this freedom and are needed when a
particular source curates a given type of data at a high
level of generality. For example, with regard to a drug-
gene interaction assertion in a source database, while it
is possible that the given drug directly interacts with the
specified gene (i.e., DNA), it is much more likely that it
binds to one of its products, though which product (e.g.,
RNA, protein, or even specific protein isoform) may not
be specified at this level of curation; furthermore, it may
not be specified whether the interacting entity is a refer-
ence sequence or a variant. (This information may not
even be known to the original researchers or the curators).
We can properly model such a curated interaction by
making use of a sequence abstraction class, asserting that
there is an interaction between the drug and the gene or
one of its products, either in the form of a reference
sequence or a variant.
Certain abstractions are necessary for the current mod-
eling being done in KaBOB and have already been
explicitly modeled and used; for example, for every
species-specific gene class, we have also created a cor-
responding abstracted class of the gene and its gene
products, which subsumes the gene class and all of its
products. Other abstractions could easily be created and
layered on additively; for example, for species-specific gene
classes, we plan on creating corresponding abstracted
homology classes, i.e., the class of a given species-specific
gene and all of its homologs. This would allow consistent
modeling of situations in which the precise identity of the
homolog (e.g.. mouse vs. human) is ambiguous in the
source information. User-defined abstractions could be
layered on as well without affecting the underlying data.
These abstractions can be formally defined as union
classes in OWL, and the rule engine can be used to
generate all of the specific classes (e.g., gene-specific,
protein-specific, etc.). Since these abstractions are formally
defined using ontologies and generated using rules that
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ger the rules, it is completely unambiguous what is meant
by any given abstraction. No implicit assumptions are
made about what is being modeled. This is not true for
systems that provide weaker definitions of the abstractions
they employ.
In addition to sequence-based abstractions KaBOB
also supports varying granularity in process-based repre-
sentations as well. Multiple rules can be applied to the
same underlying data to generate representations at
multiple layers of abstraction. For example, it is possible
to look at a pathway database that associates proteins
with a pathway and initially model that as a pathway
which obo:has_participant those proteins; this
would model the pathway at a high level of granularity.
If that pathway database also modeled the interactions
that make up the pathway or the processes that inhibit
or enable other processes, subsequent rules could be
written to extract and model that information at finer
levels of granularity. All of these rules and resultant tri-
ples can exist simultaneously and without conflict.
Representing biological sequences and processes at
multiple levels of abstraction enables users to choose a
level of specificity or generality for a given query; in fact,
different parts of a query may be specified to operate at
different levels of abstraction. Further, it requires queries
to be explicit when moving between levels of abstraction
and thus highlights where a query might be making
non-deductive steps. This rightfully places decisions on
where to make inferential leaps or how to leverage ab-
stractions on the users and tools that need these infer-
ences and abstractions. KaBOB makes no preferential
commitment to any one level of abstraction or granular-
ity and allows data and queries to exist at multiples levels
simultaneously.
Stable and reusable URIs
When generating assertions in KaBOB, many new en-
tities must be explicitly represented, including informa-
tional entities such as field values and records as well as
biomedical concepts such as proteins and interactions.
OWL also requires the generation of anonymous iden-
tifiers such as those for dynamically generated owl:
Restriction classes that are commonly modeled
using RDF blank nodes. In order to provide consistency
and stability over time, URIs for these entities are de-
terministically constructed using SHA-1 hashes of the
values that functionally define these entities; for ex-
ample, a specific field value of a specific field is deter-
ministically defined by the field name and its value.
Such hashing provides stable, unique, and consistent
URIs for these identifiers, and by using a one-way hash
function we avoid encoding data into the URIs, thus
complying with the well-established guideline for URIsto be devoid of implicit meaning. The stability of the
URIs over time supports debugging by consistently re-
generating content the same way every time, and future
work will leverage these URIs to monitor changes in
data sources over time.
These hashed URIs further enable significant savings
in terms of the number of triples by allowing representa-
tion to be shared in both ICE and BIO content. This is
most notable in the sharing of field values and OWL re-
strictions; however, it also allows different databases that
refer to the same biomedical concept, e.g., a protein-
protein interaction, to point to the same class. These
connections are made without having to look up an
existing URI or even know if there is an existing one, as
identical URIs will be minted every time. Not having to
remember or look up potentially existing URIs enables
efficient parallelization as well.
Although a hashing collision is theoretically possible with
this approach, SHA-1 should provide more than enough
space (160 bits) to avoid it empirically. The best known
theoretical attack on SHA-1 requires 269 (~5.9 × 1020)
hashes to identify a collision [49]. This is further miti-
gated by the fact that the hashed URIs have other com-
ponents as well, e.g., source-specific namespaces. A
collision would have to happen within one data source
or one type of thing represented in the BIO content,
making an extremely unlikely event even more unlikely.
There is no foreseeable need to cryptographically secure
KaBOB URIs; however, if such a need arose, SHA-2 or
SHA-3 hashes could be used instead at the cost of lon-
ger URIs.
Traceable provenance
Provenance can be tracked in two primary ways in
KaBOB. Most directly, concept-level provenance can be
assessed via the IAO links that connect ICEs to BIO
concepts, e.g., an iao:denotes link between a pro-
tein ID ICE and a protein, or between a protein-protein
interaction record ICE and the corresponding inter-
action concept in the BIO part of KaBOB. Thus, the in-
formational source of any BIO concept is directly
accessible by simply querying for the triple linking the
given ICE to its denoted biomedical concept.
The second method for acquiring provenance is by
running rules “backwards”. Every triple in KaBOB is from
one of four sources: OWL ontologies, RDF built from the
data sources, RDF output from ID set generation, or the
output of rules that use the other available triples. Every
triple can thus have its provenance dynamically re-derived
as a set of source records (and ontology parts) and rules
that created it. Note that triples in the BIO part of KaBOB
can actually have multiple sources of provenance. For ex-
ample, it is possible that two different rules and two differ-
ent sources of drug-gene interaction information lead to
Livingston et al. BMC Bioinformatics  (2015) 16:126 Page 14 of 21the same set of triples in the biomedical representations.
(It is in fact a goal of KaBOB that two sources of the same
information necessarily lead to the same biomedical
modeling). In addition to this provenance, records
themselves often have data-source-specific provenance,
e.g., the PubMed ID of the publication serving as the
evidential basis for the creation of a given data record.
These provenance data are mirrored in the record ICEs
and are readily accessible for querying. Future work
could include writing rules to extract and represent this
type of provenance more explicitly and consistently by
generating ICE-based links between the PubMed IDs
and corresponding records. By directly asserting
concept-level provenance assertions and by declara-
tively representing the transformations that generate
assertions, provenance in KaBOB is completely trans-
parent and unambiguous. This is in contrast to other
existing systems that bury these transforms and the
representational choices they make in procedural code
(e.g., a Perl script that generates triples from a data
source), which is then generally opaque to users and
reasoning systems. The approach taken by KaBOB af-
fords a more direct ability to inspect and update prov-
enance and resolve potential modeling errors when
they are uncovered. Errors resulting from bad source
data can also be traced back to their origins, some of
which we have reported to their curators.
Following up on GSEA results; a case study for using KaBOB
One common type of biomedical experiment is to run
a high-throughput microarray analysis and compare
transcription levels in case and control groups to get a
list of differentially expressed genes. Researchers will
then often report the results of GSEA (Gene Set En-
richment Analysis) [50] on that list. Frequently this is
where the analysis ends; however there are numerous
follow-up questions the researchers and readers likely
have. KaBOB can be used to answer these questions.
For example, Choi et al. [51] were interested in changes
in mitochondria in mice bred for high and low fear. They
showed that the genes differentially expressed in the pre-
frontal cortex (PFC) were enriched for the process of
oxidative phosphorylation. The authors conclude their
discussion by stating that “a better understanding of
the genes associated with the mitochondrial function in
the PFC may provide an opportunity to identify a novel
drug target for the treatment of mood and anxiety dis-
orders.” Natural follow-up questions to these results are:
“Which genes/gene products in humans, are localized
to mitochondria, involved in oxidative phosphorylation,
and are targets of drugs? And what are these drugs?”
These questions can be readily asked and answered
with KaBOB. For example, the following SPARQL 1.1
query retrieves drugs that bind to gene products thatare localized to mitochondria and are involved in oxida-
tive phosphorylation:
The query is broken into five major lettered blocks,
A-E. Section A queries for the restriction of all things
that have been found to localize in mitochondria, finds
the corresponding localization events, and retrieves the
gene products found to have localized there. For a
given gene product, section B retrieves the correspond-
ing gene-or-gene-product aggregate class, and section
C queries for which of these gene-or-gene-product clas-
ses pertain to humans. Section D then returns to the
gene-or-gene-product aggregate class and first retrieves
all of its subclasses, including itself. Note that to effectively
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one must first query for all the subclasses of the aggregate.
This allows for all of the subclasses to be queried as an ag-
gregate; if instead a variable was reused across clauses,
that query would effectively be asking for one specific
gene product known to satisfy all conditions (for which, in
this case, none would be found). Section D continues by
querying for all things in which these gene products par-
ticipate, and then selecting only those that are a subclass
of oxidative phosphorylation. Section E again gets a new
subclass of the aggregate abstraction, then retrieves all
events in which it has been found to participate, finds
other participants of these events, and then makes sure
that the second participant is realizing the role of (i.e.,
acting as) a drug in that interaction. Finally, the query
retrieves the names of the resulting drugs.
This query highlights some of the benefits of the
KaBOB representations discussed in earlier sections. Se-
quence abstractions are utilized, as seen in section B of
the query. The extensive use of subclassing is also evi-
dent throughout the query. For example, section A is
looking for the subclass of localization, that is the sub-
class of all things that result in localization to the mito-
chondria, and then queries for the other parent classes
that provide information about what is being localized.
This query also highlights the fact that the query is asked
only in terms of biomedical concepts (e.g., genes/gene
products/variants, organismal taxa, oxidative phosphoryl-
ation, mitochondria, drugs), with no informational entities
(e.g., names of specific databases, fields, identifiers) ever
referenced.
With only PharmGKB integrated as a source of drugs
and drug targets, the query above returns the two drugs
adefovir dipivoxil and tenofovir. By extending the SELECT
statement to include the variable ?gorgporv (the vari-
able representing gene-or-gene-product aggregate classes)
the query is modified to return gene-drug interacting
pairs, instead of just the drugs. Executing this query
shows that both drugs interact with the AK2 gene or its
products.
After writing three rules to also integrate DrugBank
into KaBOB using the same common biological repre-
sentation, the query can be run without changes and the
results are extended to 8 genes that collectively interact
with 26 different drugs. These eight genes include two
from the PFC gene list in Choi et al. (UQCRB, UQCRC1),
two more that are mentioned in another gene list in Choi
et al. (AK2, UQCRC2) and four that appear in neither
gene list (ATP5C1, ATP5D, COX1, UQCRH).
Looking up all the drugs that interact with the PFC
gene list produces 169 potential compounds. Running
the query above produces a far more targeted list of 26
compounds. The five in bold do not occur in the list of
169 and thus are unique to this approach; this is due tothe fact that KaBOB can identify other potentially rele-
vant genes that were not in the experimental results
that are drug targets, in this case genes involved in oxi-
dative phosphorylation that have been found to localize


































The purpose of this example is not to demonstrate
novel biomedical findings but instead to illustrate how a
complex query expressed exclusively in terms of biomed-
ical concepts, without having to know underlying database
schemas, can be formulated and issued against our inte-
grated knowledge base. However, even a brief search of
PubMed with the results from this example shows bio-
medical relevance of the results of the example query. For
example, research has been conducted looking at the ef-
fects of isoflurane and desflurane on mitochondrial func-
tion and cognition [52].
Current limitations and future work
The primary limitations of the KaBOB methods and
knowledge model are related to issues of scale. These limi-
tations include the size of the original data source files
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number of triples a given machine or piece of software
can store and query, and limits on the ability to query for
triples that are entailed but not explicitly represented.
Fortunately all of these issues are major and active areas
of research and development in the Semantic Web com-
munity and by product vendors, so in addition to our at-
tempts to mitigate them, it is likely that they will continue
to be externally addressed.
Storage of the record RDF for the all-organism version
of KaBOB takes approximately 140 GB per version. Up-
dating KaBOB monthly and preserving legacy data would
require nearly 2 TB of space per year. Part of our ongoing
research is developing a methodology to require keeping
only differences to historical data instead of complete cop-
ies, hopefully greatly reducing storage requirements. This
is potentially feasible due to our use of a common under-
lying representation for records from all source databases
and SHA-1 hashing to consistently name URIs that we
are generating, which collectively provide a high level
of consistency across versions and over time.
Early steps in the KaBOB build process are possible using
the full (all-organism) data set; however, more complicated
queries later in the build process were taking inordinate
amounts of time on our hardware/software combination
and so have been temporarily placed on hold while we
work on moving to a larger machine. Triplestores tend
to scale as a function of memory, and we believe an all-
organism KaBOB can be computed on a larger-memory
machine. Our collaborators at Franz have run some of
our test queries successfully on a 384 GB RAM machine
(4x what we are running). Machines with 500 GB or even
1,000 GB are becoming more common at supercomputing
facilities, such as those being built at the University
of Colorado, and cloud-based environments such as
Amazon’s EC2 currently rent access to 244 GB ma-
chines. We will also continue to explore other potentially
large but bounded subsets of the data, e.g., all eukaryotes.
Additionally, triplestores are continuing to improve, and
the hardware needed to run them is decreasing in cost.
We are operating on the order of 10 billion triples with
hardware costing less than US$10,000. Distributed triples-
tores are an ongoing area of research, and experimental
systems have been successfully fielded on 100 billion tri-
ples already.
KaBOB satisfies the data modeling desiderata for inte-
gration put forward by [2–4]. These papers also discuss
what is required to have a more open and federated sys-
tem of data access, but this is beyond the scope of our
work. Common models for identity, semantics, and prov-
enance are prerequisites for such a federated system, and
these are some of the problems KaBOB addresses. The
knowledge representations in KaBOB lay the foundation
for how to integrate data using the OBOs such that datafrom disparate source databases are interoperable, and this
work should be equally applicable to any future attempts
at federation. Future work could potentially enable
multiple independent end-points participating in a fed-
erated KaBOB.
Reasoning at scale can also be problematic. KaBOB
representations are predominantly currently modeled in
OWL-EL [53], which can be computed in polynomial
time, though we have yet to attempt to run a classifier
over billions of triples. (The only representational con-
struct outside of OWL-EL currently in KaBOB is union,
which is used in the formal definition of the sequence
abstraction classes as unions of base sequence types;
however, they can be represented in parallel as super-
classes of the base sequence types). There is also ongoing
work by triplestore providers to perform inference and
materialization faster and for more complicated inferences
[45,54]. Thus far we have taken advantage of SPARQL 1.1
property paths to reason through transitive properties
(e.g., subClassOf*); the performance of doing so var-
ies by triplestore. With some tuning to query ordering,
AllegroGraph can navigate these paths in satisfactory
time, with the slowest queries running on the order of
minutes to tens of minutes on our hardware. Alternately,
transitive properties could be materialized into the triples-
tore in order to get better performance. Given the way
Virtuoso currently implements property paths, such a step
would be necessary to query with multiple paths. Not all
inferences can be accessed with property paths alone, e.g.,
entailments from transitive properties or subclass hier-
archies nested in OWL restrictions. We are interested in
using OWL-EL reasoners such as ELK [55] to attempt to
make these queries tractable. Other alternatives include
using Datalog forward chainers to materialize the neces-
sary triples, such as the Allegro Graph Materializer [56] or
RDFox [57].
Querying OWL using only SPARQL can be tedious, but
this is also improving with time. SPARQL 1.1 provides sig-
nificant improvements over 1.0 via property paths. Other
APIs for querying triplestores and interacting with OWL
are also being developed by the community. We are inter-
ested in developing other APIs for common tasks and
queries, or extending our existing domain-specific lan-
guages to alleviate some of the strain. The rule language
for KaBOB, for example, makes available several macros
to significantly reduce the number of boilerplate triples
humans have to produce when interacting with record
ICEs.
As reasoning and query capabilities continue to improve
we are also interested in developing tools for maintaining
and monitoring the quality of KaBOB. This will include
research into systems that query for potentially erroneous
assertions in KaBOB, trace their provenance, and report
on the collective set of rules and source records used to
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lution for these problems being provided by human inter-
vention these assertions could be blocked from generation
in subsequent builds of KaBOB or filtered from an existing
KaBOB instance.
Related work
Related research on the semantic integration of data
sources falls into two primary classes: automated inte-
gration investigated by the computer science community
(typically database or AI researchers), and the more man-
ual but domain-specific research conducted by the bio-
informatics community.
Automated database integration
The problem of integrating multiple databases has a
history almost as old as relational databases themselves;
Doan and Halevy [58] review this work and provide links
to older reviews on this topic. Research in the database
and artificial intelligence (AI) communities on automated
data integration falls into two main categories: schema
matching and data matching. Schema matching focuses
on mapping the schema for one database to another, e.g.,
figuring out that the “Surname” column of one database
is the same as the “Last Name” column of another. Data
matching is performed using actual field values, e.g., find-
ing that a record in database A has the value “Livingston”
and database B also has the value “Livingston” for a given
record, and so on for the other values of the records.
Work on automated matching is complicated by the
fact that schemas often model data at different level of
abstraction and there is not necessarily a one-to-one map-
ping across databases. For example, one schema might
have separate fields for street address, city, and state, while
another schema might represent all of that data in an inte-
grated address field. These complex matches can be diffi-
cult to identify, as increasing the number of fields that
can be combined along with the ways in which they can
be combined can result in a combinatorial explosion.
When it comes to tuple matching there is the question
of whether or not two nearly identical tuples represent
duplicate or different data. There has also been growing
evidence that there may not be one universally correct
match, but rather that mappings are application-dependent
[58]. Domain ontologies are also being used as a backbone
for mapping multiple database schemas together [59].
KaBOB maps representations to ontologies allowing for
multiple levels of abstraction to be represented simul-
taneously. These mappings are also currently produced
manually, allowing knowledge engineers to use all avail-
able background knowledge (including database docu-
mentation) to generate the matches to the OBOs.
In the development of KaBOB we have opted for a
manually built rule-based approach to schema matching,converting the matched data into a common model
grounded in prominent biomedical ontologies. While
our approach is potentially slower than automated ap-
proaches, there are a finite number of rules to be pro-
duced. Future work could involve exploring the use of
automated mapping techniques or human-computer
hybrid techniques to accelerate the process. However,
the primary bottleneck is still creating the target know-
ledge representation for a new class of biomedical in-
formation; after a new such representation is constructed,
a second source of the same type of information can be
more easily built, copying from the first.
Doan and Halevy [58] state the core problem of seman-
tic integration is identifying if any two elements refer
to the same real-world concept. In KaBOB we expli-
citly model these mappings in terms of identifier sets
and other iao:denotes links, as well as tracking the
provenance of other concepts through declarative rules.
Provenance and explanation of matches is not always
provided by automated database integration systems,
although it is also being researched by the database
community [60].
Biomedical database integration
Interchange languages, such as BioPAX [61], GAF2
[62], and PSI MIF [63] provide a common way to rep-
resent data and are playing a growing role in the bio-
medical data ecosystem for sharing data. These data
formats have done much to increase the level of data
sharing in the community; however they are generally
domain- or task-specific. Larger database integration
projects also exist, such as BioMart [64] which pro-
vides the ability to query across multiple biomedical
data sources. While this provides a common interface,
queries are still required to know which sources they
wish to query and how the data is organized in those
individual sources. Much work has gone into produ-
cing database integrations with various configurations
and goals; Louie et al. [65] provide a review-level dis-
cussion of several existing biomedical data integration sys-
tems. The remainder of our discussion will focus on
ontology-based integration of biomedical data, as this is
most related to KaBOB.
Semantic integration and querying of multiple sources
of biomedical data dates back at least to Tambis [66],
which attempted to answer queries without the user having
to know which data sources were necessary. More recently,
there has been a push to integrate biomedical data with the
Semantic Web [67,68]. This includes work in building
canonicalized and stable URIs [69,70] as well as work on
publishing and disseminating data and recording their
provenance [71,72].
Bio2RDF [73] is the most prominent project for provid-
ing access to RDF versions of many existing biomedical
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though it does not attempt to explicitly assert sets of iden-
tifiers that point to the same entities, it does provide
access to identifier mappings; in this way it is primarily
analogous to the ICE portions of KaBOB. Additionally,
Bio2RDF does not attempt to align representations to a
common biomedical model, thus making querying across
data sources more difficult and convoluted in that query
writers must navigate all relevant component database
schemas themselves. Bio2RDF generates representations
using source-specific models and is primarily focused
on facilitating “mash-ups”. Given this focus, Bio2RDF
has weaker constraints on its representation and some-
times conflates things that should be semantically dis-
tinct. For example, the URI for glutathione in Bio2RDF
(http://bio2rdf.org/drugbank:DB00143) is ex-
plicitly asserted as rdf:type http://bio2rdf.org/
drugbank_vocabulary:Drug and implicitly as foaf:
Document (via a rdfs:domain constraint on an explicit
void:inDataset assertion). These representational in-
consistencies create a weak foundation if not real problems
for research that wishes to build upon it for semantic rea-
soning purposes. While it may be possible to build KaBOB
on top of something like Bio2RDF data, this remains an
open question and entails risks. We believe our ICE repre-
sentations provide a maximally general, and representation-
ally sound, foundation for KaBOB.
Subsequent work points out that “querying Bio2RDF
remains difficult due to the lack of uniformity in the rep-
resentation of Bio2RDF datasets” [74]. Their work attempts
to resolve this problem by aligning the source-specific
schemas of Bio2RDF to the Semanticscience Integrated
Ontology (SIO). They acknowledge that the SIO is limited
in its coverage and needs to be extended, thus introducing
a significant additional ontology development problem.
The manual mappings done by Callahan et al. [74] require
one-to-one relations between the source classes and prop-
erties in the Bio2RDF ontologies to those in the SIO, which
they acknowledge are often imprecise matches to high-
level concepts.
KaBOB makes very explicit the differences between data-
base entities and biomedical concepts, unlike Bio2RDF. Its
shared biomedical representations are grounded in prom-
inent, actively maintained, large-scale Open Biomedical
Ontologies. Compared to the SIO they have much greater
coverage, greater consensus among the community, and
are already used directly by many prominent curated data-
bases, greatly simplifying the mapping problem. KaBOB
also performs the translation from implicit database con-
tent to explicit biomedical representations using declara-
tively represented forward-chaining rules that are capable
of dynamically constructing new entities. In contrast to
approaches that only align ontology terms, this allows
mismatches between the abstractions implicitly used forcuration in the databases and those in the OBOs to be
more easily overcome, while still recording provenance.
When a rule (mapping) fails (perhaps due to changes in
the underlying data), it is also easily detected as the output
of the rule will produce zero triples, unlike mappings pro-
vided in hand-coded ontology files. Neurocommons [75]
is another ontology-based knowledge base aggregating
biomedical information from a range of sources. Precise
identifiers for records that maintain the distinction be-
tween entities such as genes and gene records have
been carefully created, and they are used for provenance
of biomedical assertions, but, unlike KaBOB, the content
of the records is not directly modeled. Record content that
has not been mapped to a common biomedical model in
Neurocommons is computationally inaccessible, and the
mappings to the model are performed via procedural
code. In KaBOB, record data is available for computational
systems in the ICE portion of the knowledge base even
if rules that map these data to biomedical representa-
tions have yet to be written or run. Furthermore,
KaBOB’s declaratively represented rules can also func-
tion as provenance for concepts in the common bio-
medical model.
There have been several other approaches to semantic
integration of biomedical data. Early work by Ruttenberg
et al. [76] discussed the need for uniformly structured
data across domains in order to advance translational re-
search. They further discuss how the Semantic Web might
provide a platform for such a taks. BioGateway [77] was
an approach that aggregated a large quantity of data using
a mixture of OBOs and custom ontologies. Like most earl-
ier work it did not make a distinction between ICE and
BIO content as does KaBOB nor does is integrate overlap-
ping content. The work by Marshall et al. [78] also has
similar goals to KaBOB; however it stops short in many
key areas, leaving as opportunities for future development
problems that KaBOB resolves, such as how to represent
and integrate concepts representing information arti-
facts and how can they be used to provide provenance. It
does solve other problems in ways that KaBOB has also
adopted, such as normalizing the identifiers in source
records. More recently work by Hoehndorf et al. [79]
demonstrates how integrating data from multiple sources
using OWL can support very complex querying. They in-
tegrate several types of data that KaBOB also provides;
however their model forces the use of certain abstractions,
for example, it is gene-centric mapping all data to genes,
as opposed to supporting multiple parallel abstractions as
does KaBOB. Their mappings are also done without mak-
ing an ICE-BIO distinction and preserving the informa-
tion entities as provenance. Finally they use equivalent
class axioms to merge entities in the biomedical represen-
tations, while KaBOB resolves these mappings at an earlier
stage with identifier mappings.
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sources of biomedical data have also been developed.
ResourceIndex [80] indexes data sources and their records
for search by using the NCBO Annotator [81] to identify
the ontology concepts mentioned in them. ResourceIndex
enriches its annotations using intra-ontology information,
such as the transitivity of the subclass hierarchy; and
inter-ontology information, such as mappings between
ontologies. NIF [82] is a neuroscience-specific environ-
ment for indexing and querying Web pages, publications,
and even databases. NIF provides the ability to use ontol-
ogies to query across data sources and even into databases
by providing an environment where data providers can
register their data and map it to the common ontologies,
and where users can issues queries that are translated into
ontology concepts and federated to all participating re-
sources. Queries can be expanded to use a neighborhood
of related ontology terms. Systems like ResourceIndex and
NIF provide incredible querying power and specificity to
users. However, these tools do not model the relationships
between concepts present in records or documents, and
they do not link or aggregate data across sources.
Existing commercial work on biomedical data integra-
tion includes Ingenuity Pathway Analysis [83], which iden-
tifies relevant molecular networks by integrating gene
expression data, gene annotations, and manually curated
data from literature. Other tools such as BioXM [84] pro-
vide a platform for data integration using a custom know-
ledge model and provide access for querying of these data.
In addition to its reliance on large, prominent biomedical
ontologies developed with significant community input
for the structuring of its integrated data, KaBOB notably
differs from these in being freely licensed.
Conclusions
We presented five processes that when collectively applied
provide solutions to seven key semantic data integration
issues. We applied these processes to 18 large biomedical
data sources to produce KaBOB (the Knowledge Base of
Biomedicine), an integrated knowledge base of biomedical
data representationally based in prominent, actively main-
tained Open Biomedical Ontologies, thus enabling queries
of the underlying data in terms of biomedical concepts
(e.g., genes and gene products, interactions and processes)
rather than features of source-specific data schemas or file
formats. In KaBOB, identity is resolved through the repre-
sentation of biomedical concepts that are referred to by
sets of identifiers, making no preferential commitments
to any identifier space. Declaratively represented forward-
chaining rules take information that is variably repre-
sented in disparate independent underlying database
models and generate representations in a common ontology-
based biomedical model but also leave the underlying source
data available for querying and provenance. These rules alsofunction to track provenance and allow all transformations
to be inspected and evaluated. Common biomedical abstrac-
tions are used to take into account the ambiguity of model-
ing within source data and to reflect this ambiguity in
queries of these data. KaBOB resolves many of the issues that
routinely plague biomedical researchers intending to work
with data from multiple data sources and provides a platform
for ongoing data integration and development and for formal
reasoning over a wealth of integrated biomedical data.Availability of supporting data
We provide and maintain the open source code that
achieves the steps described above, from downloading
source files to running the rules. Usage agreements of
some data sources prohibit redistribution so we cannot
redistribute the complete set of triples. We welcome in-
quiries about specific collaborations. We intend to de-
velop tools to expose parameterized questions for more
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OBO-based biomedical model.
Additional file 4: Appendix D. Error Detection. Appendix D provides
more detailed examples of error detection queries with KaBOB.
Additional file 5: Appendix E. DrugBank Identifier Mapping Errors.
Appendix E provides more detail to one of the examples discussed in
Appendix D.Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
KL was the primary architect of KaBOB and lead the team in its development.
He was responsible for building the rule engine, writing rules, and the overall
integration and final construction, which included developing the KR library,
and the KaBOB library being open sourced with this work. MB is the lead
ontologist for KaBOB and was primarily responsible for designing the
knowledge representations used to integrate all of the data, collaborated in the
design of KaBOB, and contributed to the writing of rules. WB was primarily
responsible for the data acquisition and rdf-ization, which included developing
the file parser library being open sourced with this work, additionally he
contributed to writing rules. LH was involved in the conception, overall
design, and planning of the project. All authors contributed to the writing
of this manuscript. All authors read and approved the final manuscript.
Livingston et al. BMC Bioinformatics  (2015) 16:126 Page 20 of 21Acknowledgements
We are especially grateful to Franz Inc. for their ongoing support of this
research by providing licensing for AllegroGraph as well extensive assistance
with and customization of their product in response to our unique needs.
Early versions of this work were developed in parallel using the bigdata
triplestore, and we appreciate the software and support that they provided
for the project. We thank Yuriy Malenkiy for his significant contributions to
the development of the file parsing and RDF generating code. We would
like to thank Judy Blake for identifying the biomedical example used in this
paper. We would also like to acknowledge our fellow lab mates who assisted
through their discussion and feedback to the project. We have also
benefited from numerous conference and meeting attendees along the way
who have discussed this work with us and provided valuable feedback and
encouragement. KL and WB received funding from NIH NLM grant
2T15LM009451. All authors have received funding from NIH NLM grants
LM008111 and LM009254.
Received: 23 October 2014 Accepted: 30 March 2015
References
1. Galperin MY, Rigden DJ, Fernández Suárez XM. The 2015 nucleic acids
research database issue and molecular biology database collection. Nucleic
Acids Res. 2015;43:D1–5.
2. Goble C, Stevens R. State of the nation in data integration for bioinformatics. J
Biomed Inform. 2008;41(5):687–93. doi: 10.1016/j.jbi.2008.01.008. Epub 2008 Feb 5.
3. Good BM, Wilkinson MD. The life sciences semantic Web is full of creeps!
Brief Bioinform. 2006;7:275–86.
4. Jain P, Hitzler P, Yeh PZ, Verma K, Sheth AP, Linked Data Is Merely More Data.
In: Dan Brickley, Vinay K. Chaudhri, Harry Halpin, and Deborah McGuinness:
Linked Data Meets Artificial Intelligence. Technical Report SS-10-07, AAAI Press,
Menlo Park, California, 2010, pp.82-86. ISBN 978-1-57735-461-1
5. Hitzler, P. Towards reasoning pragmatics. In: Janowicz, K., Raubal, M.,
Levashkin, S. (eds.) GeoSpatial Semantics, Third International Conference,
GeoS 2009, Mexico City, Mexico, December 3–4, 2009. Proceedings. pp. 9–25.
Lecture Notes in Computer Science, Springer (2009)
6. Information Artifact Ontology (IAO) [http://purl.obolibrary.org/obo/iao.owl]
7. Gene Ontology (GO) [http://purl.obolibrary.org/obo/go.owl]
8. Sequence Ontology (SO) [http://purl.obolibrary.org/obo/so.owl]
9. Basic Formal Ontology (BFO) [http://purl.obolibrary.org/obo/bfo.owl]
10. BRENDA Tissue / Enzyme Source (BTO) [http://purl.obolibrary.org/obo/bto.owl]
11. Chemical Entities of Biological Interest (ChEBI) [http://purl.obolibrary.org/
obo/chebi.owl]
12. Cell Type Ontology (CL) [http://purl.obolibrary.org/obo/cl.owl]
13. Protein-Protein Interaction Ontology (MI) [http://purl.obolibrary.org/obo/mi.owl]
14. Mammalian Phenotype Ontology (MP) [http://purl.obolibrary.org/obo/mp.owl]
15. NCBI Taxonomy [http://purl.obolibrary.org/obo/ncbitaxon.owl]
16. Ontology for Biomedical Investigation (OBI) [http://purl.obolibrary.org/obo/
obi.owl]
17. Protein Modification (MOD) [http://purl.obolibrary.org/obo/mod.owl]
18. Protein Ontology (PR) [http://purl.obolibrary.org/obo/pr.owl]
19. Relation Ontology (RO) [http://purl.obolibrary.org/obo/ro.owl]
20. Database of Interacting Proteins (DIP) [http://dip.doe-mbi.ucla.edu/dip/
Main.cgi]
21. DrugBank [http://www.drugbank.ca/]
22. Genetic Association Database (GAD) [http://geneticassociationdb.nih.gov/]
23. Gene Ontology Annotation (UniProt-GOA) Database [http://www.ebi.ac.uk/
GOA]
24. HUGO Gene Nomenclature Committee (HGNC) [http://www.genenames.org/]
25. HomoloGene [http://www.ncbi.nlm.nih.gov/homologene]
26. Human Protein Reference Database (HPRD) [http://www.hprd.org/]
27. InterPro [http://www.ebi.ac.uk/interpro/]
28. iRefWeb [http://wodaklab.org/iRefWeb/]
29. Mouse Genome Informatics (MGI) [http://www.informatics.jax.org/]
30. miRBase [http://www.mirbase.org/]
31. NCBI Gene [http://www.ncbi.nlm.nih.gov/gene]




35. Rat Genome Database (RGD) [http://rgd.mcw.edu/]36. Transfac [http://www.gene-regulation.com/pub/databases.html]
37. UniProt [http://www.uniprot.org/]
38. Bada M, Livingston K, Hunter L An ontological representation of biomedical
data sources and records. In Proc. Intelligent Systems in Molecular Biology,
Bio-Ontologies SIG. Vienna, Austria; 2011.
39. NIST. Secure hash standard (SHS) FIPS PUB 180–4. MD: Gaithersburg; 2012.
40. Hill D, Smith B, McAndrews-Hill M, Blake J. Gene ontology annotations: what
they mean and where they come from. BMC Bioinformatics. 2008;9
Suppl 5:S2.
41. KR: Clojure API for RDF and SPARQL [https://github.com/drlivingston/kr]
42. SWRL. http://www.w3.org/Submission/SWRL/
43. Kifer M. Rule interchange format: the framework. In: Calvanese D, Lausen G,
editors. Web reasoning and rule systems, vol. 5341. Berlin, Heidelberg: Springer
Berlin Heidelberg; 2008. p. 1–11. Lecture Notes in Computer Science.
44. Galler BA, Fisher MJ. An improved equivalence algorithm. Commun ACM.
1964;7:301–3.
45. Allegro Graph [http://franz.com/agraph/allegrograph/]
46. Virtuoso [http://virtuoso.openlinksw.com/]
47. Mungall CJ, Bada M, Berardini TZ, Deegan J, Ireland A, Harris MA, et al.
Cross-product extensions of the gene ontology. J Biomed Inform.
2011;44:80–6.
48. Wassink I, Vet P.E, van der Wolstencroft K, Neerincx P.B.T, Roos M,
Rauwerda, H et al. Analysing scientific workflows: why workflows not only
connect web services. In: IEEE Congress on Services 2009, 06-10 Jul 2009,
Los Angeles, CA, USA. 2009 (pp. pp. 314-321).
49. Ferguson N: Cryptography Engineering (http://www.schneier.com/book-ce. html),
John Wiley & Sons, 2010. ISBN 978-0-470-47424-2 .
50. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA,
et al. Gene set enrichment analysis: a knowledge-based approach for
interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A.
2005;102:15545–50.
51. Choi KH, Le T, McGuire J, Coyner J, Higgs BW, Diglisic S, et al. Expression
profiles of mitochondrial genes in the frontal cortex and the caudate
nucleus of developing humans and mice selectively bred for high and low
fear. PLoS One. 2012;7:e49183.
52. Zhang Y, Xu Z, Wang H, Dong Y, Shi HN, Culley DJ, et al. Anesthetics
isoflurane and desflurane differently affect mitochondrial function, learning,
and memory. Ann Neurol. 2012;71:687–98.
53. OWL 2 EL. http://www.w3.org/TR/owl2-profiles/#OWL_2_EL
54. Thompson B, Personick M: Bigdata: the semantic web on an open source
cloud. Int Semant Web Conf 2009.
55. Kazakov Y, Krötzsch M, Simancík F ELK Reasoner: Architecture and
Evaluation. In Proceedings of the {OWL} Reasoner Evaluation Workshop
(ORE’12). Edited by Horrocks I, Yatskevich M, Jimenez-Ruiz E. Manchester,
UK:CEUR-WS.org; 2012.
56. Allegro Graph Materialized Reasoner [http://franz.com/agraph/support/
documentation/current/materializer.html]
57. Motik B, Nenov Y, Piro R: Parallel materialisation of datalog programs in
centralised, main-memory RDF systems. In Proc. of the 28th Nat. Conf. on
Artificial Intelligence (AAAI 14). Québec City, Québec, Canada; 2014.
58. Doan A, Halevy AY. Semantic-integration research in the database community.
AI Mag. 2005;26:83–94.
59. Xu L, Embley D. Using domain ontologies to discover direct and indirect
matches for schema elements. \cite{DHNo03}. 2003;82:97–102.
60. Dhamankar R, Lee Y, Doan AH, Halevy A, Domingos P: iMAP discovering
complex semantic matches between database schemas. Proc 2004 ACM
SIGMOD Int Conf Manag data 2004:383–394.
61. Demir E, Cary MP, Paley S, Fukuda K, Lemer C, Vastrik I, et al. The BioPAX
community standard for pathway data sharing. Nat Biotechnol. 2010;28:935–42.
62. Chan J, Kishore R, Sternberg P, Van Auken K. The gene ontology:
enhancements for 2011. Nucleic Acids Res. 2012;40:D559–64.
63. Hermjakob H, Montecchi-Palazzi L, Bader G, Wojcik J, Salwinski L, Ceol A, et al.
The HUPO PSI’s molecular interaction format–a community standard for the
representation of protein interaction data. Nat Biotechnol. 2004;22:177–83.
64. Haider S, Ballester B, Smedley D. BioMart central portal—unified access to
biological data. Nucleic Acids Res. 2009;37 suppl 2:W23–7.
65. Louie B, Mork P, Martin-Sanchez F, Halevy A, Tarczy-Hornoch P. Data
integration and genomic medicine. J Biomed Inform. 2007;40:5–16.
66. Stevens R, Baker P, Bechhofer S, Ng G, Jacoby A, Paton NW, et al. TAMBIS:
transparent access to multiple bioinformatics information sources.
Bioinformatics. 2000;16:184–5.
Livingston et al. BMC Bioinformatics  (2015) 16:126 Page 21 of 2167. Samwald M, Jentzsch A, Bouton C, Kallesøe CS, Willighagen E, Hajagos J,
et al. Linked open drug data for pharmaceutical research and development.
J Cheminform. 2011;3:19.
68. Stephens S, LaVigna D, DiLascio M, Luciano J. Aggregation of bioinformatics
data using Semantic Web technology. J Web Semant. 2006;4:216–21.
69. Juty N, Le Novère N, Laibe C. Identifiers.org and MIRIAM Registry:
community resources to provide persistent identification.Nucleic Acids Res.
2012 Jan;40(Database issue):D580–6. doi:10.1093/nar/gkr1097.
Epub 2011 Dec 2.
70. Kuhn T, Dumontier M. Trusty URIs: Verifiable, Immutable, and Permanent.
Digital Artifacts for Linked Data. Proc. Eleventh European Semantic Web
Conference, LNCS 8465, pp. 395–410(2014).
71. Mons B, Velterop J. Nano-publication in the e-science era. In: Workshop on
Semantic Web Applications in Scientific Discourse. (SWASD 2009),
Washington DC, USA.
72. Tim C, Paolo NC, Carole A. Goble Micropublications: a semantic model for
claims, evidence, arguments and annotations in biomedical
communications. Journal of Biomedical Semantics 2014, 5:28. doi:10.1186/
2041-1480-5-28.
73. Belleau F, Nolin M-AA, Tourigny N, Rigault P, Morissette J. Bio2RDF: towards
a mashup to build bioinformatics knowledge systems. J Biomed Inform.
2008;41:706–16.
74. Callahan A, Cruz Toledo J, Dumontier M. Ontology-based querying with
Bio2RDF’s linked open data. J Biomed Semantics. 2013;4 Suppl 1:S1.
75. Ruttenberg A, Rees JA, Samwald M, Marshall MS. Life sciences on the
Semantic Web: the Neurocommons and beyond. Brief Bioinform.
2009;10:193–204.
76. Ruttenberg A, Clark T, Bug W, Samwald M, Bodenreider O, Chen H, et al.
Advancing translational research with the Semantic Web. BMC
Bioinformatics. 2007;8 Suppl 3:S2.
77. Antezana E, Blondé W, Egaña M, Rutherford A, Stevens R, De Baets B, et al.
BioGateway: a semantic systems biology tool for the life sciences. BMC
Bioinformatics. 2009;10 Suppl 10:S11.
78. Marshall MS, Prud’hommeaux E, Ruttenberg A, Rees J, Stephens S, Samwald M,
et al. A prototype knowledge base for the life sciences. 2008.
79. Hoehndorf R, Dumontier M, Gkoutos GV. Identifying aberrant pathways
through integrated analysis of knowledge in pharmacogenomics.
Bioinformatics. 2012;28:2169–75.
80. Jonquet C, Lependu P, Falconer S, Coulet A, Noy NF, Musen MA, et al. NCBO
Resource Index: Ontology-based search and mining of biomedical resources.
J Web Semant. 2011;9:316–24.
81. Jonquet C, Shah NH, Musen MA. The Open Biomedical Annotator. AMIA
Summit on Translational Bioinformatics 2009:56–60
82. Gupta A, Bug W, Marenco L, Qian X, Condit C, Rangarajan A, et al. Federated
access to heterogeneous information resources in the Neuroscience
Information Framework (NIF). Neuroinformatics. 2008;6(3):205–17.
doi:10.1007/s12021-008-9033-y. Epub 2008 Oct 29.
83. Ingenuity Pathways Analysis [http://www.qiagen.com/ingenuity]
84. Losko S, Heumann K. Semantic data integration and knowledge management
to represent biological network associations. Methods Mol Biol. 2009;563:241–58.Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
